Sign in
4

Changes in Ownership

MapLight Therapeutics, Inc. Filed Acc 0002021233-26-000008

Chief Medical Officer sold 50,280 shares at an average $28.39 ($1,427,594)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Foff Erin Pennock Chief Medical Officer 2026-05-04 Sale 10b5-1 −9,180 $27.50 $252,450 391,597 D
Foff Erin Pennock Chief Medical Officer 2026-05-04 Sale 10b5-1 −5,460 $28.37 $154,900 386,137 D
Foff Erin Pennock Chief Medical Officer 2026-05-04 Sale 10b5-1 −312 $29.56 $9,223 385,825 D
Foff Erin Pennock Chief Medical Officer 2026-05-04 Sale 10b5-1 −700 $30.08 $21,056 385,125 D
Foff Erin Pennock Chief Medical Officer 2026-05-05 Sale 10b5-1 −9,645 $28.12 $271,217 375,480 D
Foff Erin Pennock Chief Medical Officer 2026-05-05 Sale 10b5-1 −931 $29.00 $26,999 374,549 D
Foff Erin Pennock Chief Medical Officer 2026-05-06 Sale 10b5-1 −8,152 $28.04 $228,582 366,397 D
Foff Erin Pennock Chief Medical Officer 2026-05-06 Sale 10b5-1 −15,900 $29.13 $463,167 350,497 D
Open-market sales · 50,280 sh · avg $28.39 · $1,427,594
Loading xslF345X06/form4-05062026_080507.xml…